Evidence map›Paper›PMID 40661291›Full record

ArticlemedRxiv : the preprint server for health sciences2025

Predicting conversion from mild cognitive impairment to Alzheimer's disease using a Vision Transformer and hippocampal MRI slices.

René Seiger, Peter Fierlinger

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

René SeigerTechnical University of Munich, TUM School of Natural Sciences, Physics Department, Garching, Germany.ORCID 0000-0003-1556-4346
Peter FierlingerTechnical University of Munich, TUM School of Natural Sciences, Physics Department, Garching, Germany.

Funding

Project 1U19AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI MICHAEL W WEINER · 2016 to 2026
$226.7M
NIA NIH HHS U19 AG024904
6 · The paper itself

Abstract

Convolutional neural networks (CNNs) have been the standard for computer vision tasks and are frequently applied in medical conditions, such as in Alzheimer's disease (AD). Recently, Vision Transformers (ViTs) have been introduced, which provide a strong alternative to CNNs by discarding the convolution approach in favor of the attention mechanism. This allows modeling global and distant relationships within distinct parts of an image without relying on the strong inductive biases present in CNNs. A common precursor stage of AD is a syndrome called mild cognitive impairment (MCI). However, not all individuals diagnosed with MCI progress to AD. The establishment of reliable classification models that predict converters versus non-converters would be a valuable tool to support clinical decision-making, such as enabling early treatment. Hence, in this investigation a transfer learning approach was used by applying a pretrained ViT model, fine-tuned on the ADNI dataset comprising 575 subjects with MCI. We included baseline T1-weighted structural MRI data from 299 stable MCI and 276 progressive MCI individuals, who developed Alzheimer's disease within 36 months. Inputs to the model were three normalized axial slices covering areas of the hippocampal region, consisting of the combined gray and white matter segmentations. The final model was evaluated over multiple runs to obtain stable performance estimates, yielding an average area under the receiver operating characteristic curve (AUC-ROC) on the test set of 0.74 ± 0.02 (mean ± SD), an accuracy of 0.69 ± 0.03, a sensitivity of 0.65 ± 0.07, a specificity of 0.72 ± 0.06, and a F1-score for the pMCI class of 0.67 ± 0.04. By specifically focusing on axial slices covering the hippocampal region, we aimed to target the brain structure often reported as being the first affected by the disease, while our results indicate that a ViT approach achieves reasonable classification accuracy for predicting the conversion from MCI to AD.

Identifiers

PMID40661291
PMCPMC12258745

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.